Sigachi Industries Ltd

The transcript does not mention any current or future plans for fundraising through debt or equity. Key points related to finances from the document include: - The company is focusing on insurance claims to cover losses from the fire incident, including rebuilding and plant setup costs. - Insurance proceeds are expected to be sufficient for the rebuilding and restarting of operations (including plant, machinery, and building). - There is no mention of raising fresh funds via equity or debt at this time. - The company is assessing various recovery plans (Plan A, B, C) depending on access to facilities and timelines. - Emphasis is on operational recovery and utilizing insurance proceeds, rather than external fundraising. In summary, Sigachi Industries is currently relying on insurance and operational adjustments rather than planning new debt or equity fundraising.

- The insurance amount received is expected to cover the entire capex needed to rebuild the Hyderabad facility, including plant, machinery, and building. (Page 14) - Detailed capex estimates are pending full access and assessment of the damaged facility. (Page 14) - The company is planning to resume operations at Hyderabad plant within approximately 6 months. (Page 7) - Commercialization of the new CCS (Co-Processed Cellulose & Starch) facility at Dahej is progressing steadily and expected to be on track by October 2026. (Page 9) - Sigachi has secured terms of reference for an upcoming bulk drug and specialty chemical unit at Orvakal, Andhra Pradesh, reinforcing vertical integration goals. (Page 4) - Collaboration with Respilon Group S.R.O for drug delivery technology indicates a strategic investment in advanced pharma tech. (Page 4) Overall, capex focuses on rebuilding post-incident facilities, expanding CCS capacity, new specialty drug units, and innovation through partnerships.

- FY26 API revenue is expected to reach around INR 70 crores, growing steadily month-on-month from INR 9 crores in Q1. - EBITDA margin for API segment projected between 18% to 20%. - MCC segment to maintain similar capacity levels (~19,000 MT), with the Hyderabad unit (6,400 MT) being restored post-incident. - Partial revenue loss of approx. INR 60 crores from Hyderabad plant in next 6 months, with some recovery from other units (Dahej, Jhagadia). - Capacity expansion in CCS facility on track for October 2026 with no significant delays expected. - Over 2-3 years, API share in revenue mix expected to increase, possibly reducing MCC’s share from current ~80-85% to around 75%. - Working capital days aimed to be reduced from current 193 days to below 90 days by end FY26. - Business interruption insurance expected to cover revenue losses and help maintain bottom-line growth despite disruptions.

- For FY '26, Sigachi expects around INR70 crores revenue from the API segment with an EBITDA margin of 18-20%. - Despite a fire incident affecting the Hyderabad unit, the company anticipates revenue of INR550-575 crores this year, factoring in recovery from other units. - Insurance claims are expected to cover losses and help avoid major bottom-line impact. - Post-incident, management aims to restore the Hyderabad plant capacity (6,400 tons) ASAP; alternate plans are in place if delays occur. - MCC segment capacity will be maintained with planned capacity expansion ongoing smoothly. - Working capital days are targeted to reduce from 193 to under 90 by end FY ’26. - Bottom line expected to see growth if insurance claims are received timely; overall margin impact expected to be limited. - Long-term growth driven by increasing API contributions and capacity expansions in CCS and O&M verticals.

- No explicit details on the current or expected order book or pending orders were provided in the transcript. - The company indicated minimal export orders currently in the API segment, with expected revenue of around INR70 crores by FY '26 driven primarily by domestic and Rest of World (ROW) markets. - The management expressed strong customer support despite a recent incident, indicating confidence in regaining and maintaining order volumes post-disruption. - Discussions with customers are ongoing to manage business continuity and fulfill supply commitments as capacities normalize. - The CCS facility capacity expansion is on track for October 2026, which should support future order fulfillment. - Overall, visibility on precise pending order quantities or backlog figures was not shared in the call.